Real-time enrollment status for this lung cancer clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 12:06 AM UTC
| NCT Number | NCT06627647 |
| Recruiting Status | Recruiting |
| Condition | Lung Cancer |
| Phase | PHASE3 |
| Target Enrollment | 1,160 participants |
| Active Locations | 77 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | July 14, 2026 (5 days ago) |
As of July 19, 2026: Clinical trial NCT06627647 is currently recruiting participants. This phase3 study for lung cancer is actively seeking new participants at 77 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06627647 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 77 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06627647 was last updated 5 days ago (July 14, 2026). HelloStudys verifies this status automatically.